In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neena Brizmohun

Neena Brizmohun writes and commissions news, features and analysis to meet the regulatory, business and market access information needs of the companies and regulatory agencies that operate in the pharmaceutical and medical device space worldwide.

Her areas of expertise include the cutting-edge early market access schemes that are being trialed around the world for taking drugs and medical devices to market faster. She is also interested in initiatives for harmonizing regulations at the global level as well as issues affecting clinical trials, manufacturing and post-market safety monitoring. She explores the challenges and opportunities that these issues introduce for both industry and the regulators and is on a constant look out for what might be coming next.

A scientist by training, Neena started her journalistic career at Informa in 1997. She has been the deputy editor of Scrip Regulatory Affairs since 2007. Prior to that, she worked as the science editor for Clinica Medtech Intelligence. Before becoming a journalist she worked as a biomedical scientist at St Thomas' Hospital in London for 10 years.
Set Alert for Articles By Neena Brizmohun

Latest From Neena Brizmohun

Scottish HTA OKs Kymriah For Lymphoma After Novartis Drops Price

Scotland’s health technology assessment body has reversed its earlier decision to reject Kymriah for DLBCL.

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.

Europe Drug Review

Danish Regulator Offering Free Advice On How to Comply With New EU Regulations

The Danish Medicines Agency is testing a new regulatory advice service that medical device SMEs and start-ups anywhere in the world can apply to use.

Denmark Regulation

Australia To Improve Compliance For Device Systems And Procedure Packs

The Therapeutic Goods Administration is seeking feedback on proposals affecting manufacturers of packages containing therapeutic goods, at least one of which is a medical device or IVD.

Australia Compliance

Application Deadline Nears For Inclusion In WHO Essential IVD List

The World Health Organization wants to add more tests to the next edition of its Model List of Essential In Vitro Diagnostics.

Policy Healthcare Systems

HRT: European Agencies Scrutinizing New Higher Breast Cancer Risk Data

A major new study showing that the risk of breast cancer in women taking hormone replacement therapy is double previous estimates has prompted UK and EU regulatory agencies and England’s health technology assessment body to look further into the matter.

Drug Safety Cancer
See All